Welcome to Mediso

Please select your region:

North America
Europe
Pacific
Rest of the World

Please select your language:

Go

AnyScan® TRIO-TheraMAX SPECT/CT

Diagnostic & Theranostic Imaging at MAXimum level

Ultra-high energy, Extreme sensitivity, Designed for NM

AnyScan® TRIO-TheraMAX SPECT/CT

Features & Benefits

Extreme Sensitivity

  • 1620 kcps/(MBq/cm)* provided by the UHD-Digital™ Triple-NaI-Detector featuring 15.9 mm crystal thickness 
  • Ultra-Fast quantitative SPECT instead of planar scans 
  • Theranostic imaging for isotopes with 25 - 640 keV energies  

* *(Volume System Sensitivity/Axial cm2) x Axial FOV Measured with Uniform Mode & LEHR-HS collimator 

UHD-Digital™ Triple-NaI-Detector

  • Theranostic imaging for isotopes up to 640 keV provided by 15.9 mm NaI crystal (akár ez is lehetne a Feature 2 cím) 
  • Detector intrinsic resolution of 3.3 mm (FWHM) maintained by 123 PMTs  
  • 40 cm Long Axial-FOV for quick Total-body SPECT imaging 
  • Sensitivity Gain of 11% - 20% - 30% - 45% - 75% - 80% for 99mTc - 123I - 177Lu - 67Ga - 131I – 225Ac isotopes

Transformable™ Gantry

  • Flexibility to change from General-Purpose to Dedicated Imaging with a Simple Collimator Exchange;  
  • Five distinctive imaging modes including Total-body, Brain Focus, Heart Focus, Dual head planar, Dual head 90 
  • Continuous Gantry rotation for Ultra-Fast SPECT acquisitions 

The Art of Collimator Design

Routine Diagnostic Imaging at maximized Performance
High Resolution-High Sensitivity collimators:

  • Low Energy High Resolution & High Sensitivity (LEHR-HS),
  • Low Energy Ultra High Resolution & High Sensitivity (LEUHR-HS),
  • Medium Energy High Resolution & High Sensitivity (MEHR-HS)

Diagnostic & Theranostic Imaging at maximized Performance
Wide Energy Range collimators:

  • Medium to Low Energy General Purpose (M-LEGP),
  • Medium to High Energy General Purpose (M-HEGP),
  • High to Ultra-High Energy General Purpose (H-UHEGP)

Diagnostics with absolutely maximized performance:

  • MPH-Brain (Low to Medium Energy) collimator,
  • MPH-Cardiac (Low to Medium Energy) collimator

Tera-Tomo™ 3D SPECT Reconstruction

Quantitative and Reproducible Image Reconstruction

  1. GPU accelerated 3D Iterative reconstruction
  2. Multi-isotope and multi-energy window support
  3. Optimized protocols for clinical application
  4. PSF model based, Resolution Recovery, Attenuation Correction, Scatter Correction
  5. Retrospective Image Reconstruction using LIST MODE

Applications

Total Body 177Lu-PSMA-617 SPECT/CT scan

177Lu-PSMA-617 therapy demonstrated superiority compared to the standard of-care (usually a second novel-generation androgen-axis drug) with regard to progression-free survival and overall survival as well as quality of life in case of prostate adenocarcinomas.

  • MAX Edition, Triple-NaI-Detector SPECT:

MAX-123 up to 640 keV @ 2.5 mm intrinsic resolution

  • Excellent count rate performance
  • 50% more sensitivity with Triple-NaI-Detector
  • Reconstruction:

Less than 4% uncertainty in absolute quantitation for 177Lu, with TeraTomoTM SPECT 3D-Q real time Monte Carlo modelling image reconstruction

  • PET-Like image quality with High Resolution High Sensitivity MEHR-HS collimator

99mTc-PSMA-GCK01

Screening for Phenotyping PSMA positivity and therapy monitoring is possible with 99mTc-PSMA-GCK01 Total Body SPECT/CT.

  • MAX Edition, Triple-NaI-Detector SPECT:

MAX-123 up to 640 keV @ 2.5 mm intrinsic resolution

  • Excellent count rate performance
  • 50% more sensitivity with Triple-NaI-Detector
  • Reconstruction:

Less than 4% uncertainty in absolute quantitation for 99mTc with TeraTomoTM SPECT 3D-Q real time Monte Carlo modelling image reconstruction

  • PET-Like image quality with High Resolution High Sensitivity LEHR-HS collimator

Total-Body 99mTc-MDP Bone scan

Total-Body SPECT/CT 

123I-Ioflupane DATScan SPECT

Focused Brain SPECT using 123I-FP-CIT a dopamine transporter (DAT) ligand, supports differentiation between Parkinson Disease (PD) and Secondary Parkinson Syndrome (SPS) in case of a considerable fraction of patients called Clinically Uncertain Parkinson Syndrome.

99mTc-sestamibi Coronary Flow Reserve (CFR)

Coronary Flow Reserve (CFR) calculated from STRESS/REST Blood Flow helps to identify patients with Microcirculatory disease, Diffuse disease, Triple-vessel stenosis or Non-responders to pharmacological stress.

How can we help you?

Contact us for technical information and / or support related to our products and services.

Get in touch